HK1164833A1 - -氨基- -五甲基環己烷甲磺酸鹽的合成 - Google Patents

-氨基- -五甲基環己烷甲磺酸鹽的合成

Info

Publication number
HK1164833A1
HK1164833A1 HK12105346.6A HK12105346A HK1164833A1 HK 1164833 A1 HK1164833 A1 HK 1164833A1 HK 12105346 A HK12105346 A HK 12105346A HK 1164833 A1 HK1164833 A1 HK 1164833A1
Authority
HK
Hong Kong
Prior art keywords
synthesis
amino
pentamethylcyclohexane mesylate
pentamethylcyclohexane
mesylate
Prior art date
Application number
HK12105346.6A
Other languages
English (en)
Inventor
馬庫斯．亨里西
西蒙娜．尼古娜
杰格瑞．塔斯
派．克賽
費德里克．思博洛基
邁克爾．派林
赫伯特．科勒
Original Assignee
德國麥氏大藥廠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 德國麥氏大藥廠 filed Critical 德國麥氏大藥廠
Publication of HK1164833A1 publication Critical patent/HK1164833A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C07C209/14—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups
    • C07C209/16—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82—Purification; Separation; Stabilisation; Use of additives
    • C07C209/84—Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82—Purification; Separation; Stabilisation; Use of additives
    • C07C209/86—Separation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK12105346.6A 2009-04-17 2012-06-01 -氨基- -五甲基環己烷甲磺酸鹽的合成 HK1164833A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21401509P 2009-04-17 2009-04-17
EP09005471 2009-04-17
PCT/EP2010/002361 WO2010118889A1 (en) 2009-04-17 2010-04-16 Synthesis of 1-amino-1,3,3,5,5-pentamethylcyclohexane mesylate

Publications (1)

Publication Number Publication Date
HK1164833A1 true HK1164833A1 (zh) 2012-09-28

Family

ID=40942504

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12105346.6A HK1164833A1 (zh) 2009-04-17 2012-06-01 -氨基- -五甲基環己烷甲磺酸鹽的合成

Country Status (16)

Country Link
US (1) US8784847B2 (zh)
EP (1) EP2419402B1 (zh)
JP (1) JP6076736B2 (zh)
KR (1) KR20120006059A (zh)
CN (1) CN102438981B (zh)
AR (1) AR078221A1 (zh)
AU (1) AU2010237271B2 (zh)
BR (1) BRPI1011322A2 (zh)
CA (1) CA2758756A1 (zh)
ES (1) ES2605582T3 (zh)
HK (1) HK1164833A1 (zh)
IL (1) IL215352A0 (zh)
MX (1) MX2011010750A (zh)
RU (1) RU2513090C2 (zh)
TW (1) TW201040130A (zh)
WO (1) WO2010118889A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013072050A1 (en) 2011-11-15 2013-05-23 Merz Pharma Gmbh & Co. Kgaa Neramexane mesylate monohydrate and anhydrate

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE164834T1 (de) * 1993-12-03 1998-04-15 Ono Pharmaceutical Co Amidinophenolderivate mit phospholipase a2 inhibitorischer wirkung
RO117913B1 (ro) * 1996-01-02 2002-09-30 Aventis Pharmaceuticals Inc. Derivaţi de n-[(amino-(imino)metil)fenil]propil amide substituite, compoziţie farmaceutică care îi conţine şi metodă de tratament
TW593225B (en) * 1997-06-30 2004-06-21 Merz Pharma Gmbh & Co Kgaa 1-amino-alkylcyclohexane NMDA receptor antagonists
DE60324776D1 (de) * 2002-03-15 2009-01-02 Antibioticos Spa Verfahren zur synthese von pergolid
FR2869913B1 (fr) * 2004-05-04 2009-01-23 Appia Composition tensioactive, procede de preparation et cosmetique comprenant cette composition
US20060002999A1 (en) * 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
ES2340189T3 (es) * 2004-12-23 2010-05-31 Xenoport, Inc. Profarmacos de propofol derivados del aminoacido serina, composiciones, usos y formas cristalinas de los mismos.
WO2006094674A1 (en) * 2005-03-07 2006-09-14 Michael Hermanussen Nmda receptor antagonists in the medical intervention of metabolic disorders
WO2006094574A1 (de) 2005-03-11 2006-09-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zum herstellen einer nanostruktur auf einem substrat
US20070141148A1 (en) 2005-11-30 2007-06-21 Merz Pharma Gmbh & Co. Kgaa Neramexane MR matrix tablet
ZA200805511B (en) * 2005-12-05 2010-02-24 Xenoport Inc Levodopa prodrug mesylate, compositions thereof, and uses thereof
EP2046787B1 (en) * 2006-08-01 2011-04-06 Glaxo Group Limited Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors

Also Published As

Publication number Publication date
JP6076736B2 (ja) 2017-02-08
IL215352A0 (en) 2011-12-29
AU2010237271A1 (en) 2011-10-20
TW201040130A (en) 2010-11-16
MX2011010750A (es) 2011-10-24
EP2419402B1 (en) 2016-08-31
CA2758756A1 (en) 2010-10-21
JP2012524036A (ja) 2012-10-11
CN102438981B (zh) 2015-04-22
KR20120006059A (ko) 2012-01-17
RU2011146633A (ru) 2013-05-27
WO2010118889A1 (en) 2010-10-21
AU2010237271B2 (en) 2015-08-20
BRPI1011322A2 (pt) 2018-09-18
US20120100184A1 (en) 2012-04-26
US8784847B2 (en) 2014-07-22
ES2605582T3 (es) 2017-03-15
AR078221A1 (es) 2011-10-26
RU2513090C2 (ru) 2014-04-20
CN102438981A (zh) 2012-05-02
EP2419402A1 (en) 2012-02-22

Similar Documents

Publication Publication Date Title
SG176651A1 (en) Hmo synthesis
ZA201200261B (en) Cyclohexene 1,4-carboxylates
IL213794A0 (en) Novel uses
GB201019812D0 (en) Dichtungsanordnung fur die kraftfahrzeugstirnwand
PL2516292T3 (pl) Wspólnie pakowane produkty
GB201001395D0 (en) Product
GB2475492B (en) Fischer-Tropsch synthesis
GB0913488D0 (en) Product
SI2470166T1 (sl) Novi sestavki 1-(2-(2,4-dimetil-fenislulfanil)-fenil)piperazina
AU329805S (en) Bar stool
IL219336A0 (en) Metl-granulated cinacalcet
GB0916978D0 (en) Product
PL2090199T3 (pl) Tułów
EP2508335A4 (en) FLEXIBLE MATRIX
GB2483195B (en) Novel uses
GB0900870D0 (en) Loo 2
HK1162032A1 (zh) -三氟- -羥基丙基化合物
GB0823366D0 (en) Synthesis
HK1164833A1 (zh) -氨基- -五甲基環己烷甲磺酸鹽的合成
EP2513131A4 (en) NOVEL 3'-DEOXY-3'-METHYLIDENE-L-NUCLEOSIDES
HK1131529A1 (en) Torso
HRP20130485T1 (en) Method of preparing 1-amino-1,3,3,5,5-pentamethylcyclohexane
GB201004867D0 (en) Regulated descender
EP2493476A4 (en) DEUTERATED 5,6-DIHYDRO-1H-PYRIDINE-2-ON COMPOUNDS
GB0917973D0 (en) Chin up bar

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190413